MG53 compositions and methods of use
    2.
    发明授权
    MG53 compositions and methods of use 有权
    MG53组合物和使用方法

    公开(公告)号:US07981866B2

    公开(公告)日:2011-07-19

    申请号:US12307303

    申请日:2007-07-11

    IPC分类号: A61K38/17 A61K38/39

    摘要: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

    摘要翻译: 本文公开了编码新型多肽的核酸序列。 还公开了由这些核酸序列编码的多肽,以及免疫特异性结合多肽的抗体以及上述多肽,多核苷酸或抗体的衍生物,变体,突变体或片段。 本发明还公开了用于诊断,治疗和预防与这些新型人核酸和蛋白质中的任一种相关的病症的治疗,诊断和研究方法。

    COMPOSITIONS AND METHODS TO MODULATE CELL MEMBRANE RESEALING
    4.
    发明申请
    COMPOSITIONS AND METHODS TO MODULATE CELL MEMBRANE RESEALING 有权
    组合物和调节细胞膜受体的方法

    公开(公告)号:US20090208473A1

    公开(公告)日:2009-08-20

    申请号:US12328646

    申请日:2008-12-04

    摘要: Disclosed herein are compositions and methods for repairing cell membranes. In addition, the invention relates to therapeutic compositions comprising nucleotides and/or polypeptides of the invention in combination with a pharmaceutically acceptable carrier, wherein the composition facilitates the repair of cell membranes. Moreover, the invention relates to the treatment and/or prevention of pathological conditions associated with cell membrane damage.

    摘要翻译: 本文公开了用于修复细胞膜的组合物和方法。 此外,本发明涉及包含与药学上可接受的载体组合的本发明的核苷酸和/或多肽的治疗组合物,其中所述组合物促进细胞膜的修复。 此外,本发明涉及治疗和/或预防与细胞膜损伤相关的病理状况。

    Compositions and methods to modulate cell membrane resealing
    5.
    发明授权
    Compositions and methods to modulate cell membrane resealing 有权
    调节细胞膜再密封的组成和方法

    公开(公告)号:US09458465B2

    公开(公告)日:2016-10-04

    申请号:US12328646

    申请日:2008-12-04

    摘要: Disclosed herein are compositions and methods for repairing cell membranes. In addition, the invention relates to therapeutic compositions comprising nucleotides and/or polypeptides of the invention in combination with a pharmaceutically acceptable carrier, wherein the composition facilitates the repair of cell membranes. Moreover, the invention relates to the treatment and/or prevention of pathological conditions associated with cell membrane damage.

    摘要翻译: 本文公开了用于修复细胞膜的组合物和方法。 此外,本发明涉及包含与药学上可接受的载体组合的本发明的核苷酸和/或多肽的治疗组合物,其中所述组合物促进细胞膜的修复。 此外,本发明涉及治疗和/或预防与细胞膜损伤相关的病理状况。